• About Fuad El-Hibri
• Log in

• Abdul Aziz Said
• American Society of Hematology
• American University
• Arab
• BacilleCalmette-Guerin
• BioDefense
• biotechnology
• Biotechnology and Pharmaceuticals
• BioThrax
• Board of Trustees
• Business
• CEO
• Chief executive officer
• Chief financial officer
• Chief Medical Officer
• Chief operating officer
• Clinical trial
• colleagues
• Crisis
• disease
• Dr. Mary Elizabeth King
• El-Hibri
• El-Hibri Fuad
• El-Hibri Peace Education Prize
• Emergent
• Emergent BioSolutions
• Emergent BioSystems
• Entrepreneur
• Ernst & Young
• Ernst & Young Entrepreneur of the Year
• Federal government of the United States
• Financial Performance
• Financial Results
• Food and Drug Administration
• Food and Drug Administration
• Foundation
• Fuad El-Hibri
• Fuad Elhibri
• Healthcare
• Healthcare Conference
• Hematology
• Hudson Institute
• Ibrahim El-Hibri
• Ibrahim Y. El-Hibri
• Investors
• Lebanese
• Lymphocyte
• Lymphoma
• Maryland
• Medical
• Music
• National Health Museum
• North Atlantic Treaty Organization
• NuThrax
• NYSE
• Peace Education
• Resource Center
• Revenue
• Sage Hall
• Scholars Program
• Securities and Exchange Commission
• Shareholders
• South Africa
• TB Vaccine
• Tech Council of Maryland
• technology
• Trubion Pharmaceuticals
• Tuberculosis Vaccine
• U.S. Food and Drug Administration
• Uncategorized
• United States
• United States Department of Defense
• United States Department of Health and Human Services
• Vaccine
• Washington
• World Health Organization
• World TB
• Yale University

Category Archives: Food and Drug Administration

1. Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government October 14, 2011

   Posted in BioDefense, BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, U.S. Food and Drug Administration.

   No comments
2. Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule June 7, 2011

   Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri.

   No comments
3. Emergent BioSolutions Announces Initiation of Phase Ib/II Study of TRU-016 in Combination with Bendamustine for Chronic Lymphocytic Leukemia February 1, 2011

   Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Lymphocyte, Tuberculosis Vaccine.

   No comments
4. Emergent BioSolutions Completes Acquisition of Trubion Pharmaceuticals November 4, 2010

   Posted in Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Trubion Pharmaceuticals.

   No comments
5. Fuad El-Hibri and The National Health Museum September 30, 2010

   Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, National Health Museum.

   No comments
6. Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians July 13, 2010

   Posted in BioThrax, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Food and Drug Administration, Fuad El-Hibri, United States Department of Defense, United States Department of Health and Human Services.

   No comments
7. Emergent BioSolutions to Participate in June 2010 Investor Conferences June 7, 2010

   Posted in Business, Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Healthcare Conference, United States.

   No comments
8. Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland May 18, 2010

   Posted in Chief executive officer, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, Maryland, Tech Council of Maryland, Washington.

   No comments